CV Sciences, Inc. Reports Second Quarter 2018 Financial Results
01 août 2018 08h45 HE
|
CV Sciences, Inc.
Growth and Profitability Driven by Key Financial Performance Metrics, including Record GAAP Net Income of $3.2 MillionManagement to Host Second Quarter 2018 Financial Results Conference Call on August...
CV Sciences, Inc. Issues Letter to Shareholders
27 juin 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, June 27, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the industry-dominating brand...
CV Sciences, Inc. to Present at 8th Annual LD Micro Invitational on June 4-6, 2018 in Bel-Air, California
22 mai 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, May 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent manufacturer and distributor of the leading brand of hemp...
CV Sciences, Inc. Repays Installment Obligation on Convertible Debt
04 avr. 2018 08h45 HE
|
CV Sciences, Inc.
Company Further Reduces Debt and Avoids Dilution to Stockholders LAS VEGAS, April 04, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”)...
CV Sciences, Inc. to Exhibit and Present at the 2018 Integrative Health Symposium Annual Conference in New York, New York – February 22-24, 2018
24 janv. 2018 08h45 HE
|
CV Sciences, Inc.
LAS VEGAS, Jan. 24, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that it will be exhibiting its industry-dominating brand of...